Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations

Overview of attention for article published in PharmacoEconomics, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy: 1 policy source
twitter: 20 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 18 May 2019

#HealthEconJA Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall…